Qualigen Therapeutics, Inc. (QLGN) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 12 transactions totaling $112.1K, demonstrating a bullish sentiment with $112.1K in net insider flow. The most recent transaction on Jun 22, 2022 involved a purchase of 30,000 shares valued at $17.1K.
No significant insider buying has been recorded for QLGN in the recent period.
No significant insider selling has been recorded for QLGN in the recent period.
Based on recent SEC filings, insider sentiment for QLGN is bullish with an Insider Alignment Score of 100/100 and a net flow of $112.1K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Qualigen Therapeutics, Inc. (QLGN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading QLGN stock, having executed 12 transactions in the past 90 days. The most active insider is Kurt H. Kruger (Executive), who has made 5 transactions totaling $42.4K.
Get notified when executives and directors at QLGN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 22, 2022 | S. Poirier Michael | Executive | Purchase | 30,000 | $0.57 | $17.1K | |
| Jun 14, 2022 | S. Broidrick Amy | Executive | Purchase | 30,000 | $0.62 | $18.6K | |
| Aug 19, 2021 | H. Kruger Kurt | Executive | Purchase | 4,000 | $1.22 | $4.9K | |
| Aug 19, 2021 | H. Kruger Kurt | Executive | Purchase | 4,000 | $1.23 | $4.9K | |
| Apr 26, 2021 | S. Broidrick Amy | Executive | Purchase | 4,500 | $2.03 | $9.1K | |
| Apr 20, 2021 | S. Poirier Michael | Executive | Purchase | 11,005 | $1.80 | $19.8K | |
| Apr 16, 2021 | L. Lotz Christopher | Executive | Purchase | 2,700 | $1.86 | $5.0K | |
| Dec 29, 2020 | H. Kruger Kurt | Executive | Purchase | 4,000 | $2.94 | $11.8K | |
| Nov 23, 2020 | H. Kruger Kurt | Executive | Purchase | 4,600 | $3.46 | $15.9K | |
| Nov 20, 2020 | H. Kruger Kurt | Executive | Purchase | 1,400 | $3.55 | $5.0K | |
| May 22, 2020 | L. Lotz Christopher | Executive | Other | 9,841 | $N/A | $0 | |
| May 22, 2020 | S. Poirier Michael | Executive | Other | 169,192 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 10 | $112.1K | 100.0% |
Other(J) | 2 | $0 | 0.0% |
Insiders at Qualigen Therapeutics, Inc. are accumulating shares at an accelerated pace. With 4 insiders making 12 transactions totaling $112.1K in purchases versus $0 in sales, the net buying activity of $112.1K signals strong executive confidence. Kurt H. Kruger (Executive) leads the buying activity with $42.4K in transactions across all time.